Canada proposes publishing its post-authorisation decisions for drugs and devices
This article was originally published in Clinica
Executive Summary
Health Canada has issued proposals for the second phase of its transparency initiative, under which the government department is planning to make available information on decisions relating to its post-authorisation activities for certain drugs and medical devices.